[Class : 5] Medicinal Preparations; Medicinal Healthcare Preparations; Medicinal Preparations And Substances; Pharmaceuticals; Homeopathic Pharmaceuticals; Pharmaceuticals, Medical And Veterinary Preparations; Dermatological Preparations; Solutions For Dermatological Use; Creams For Dermatological Use; Para Pharmaceutical Preparations For Use In Dermatology; Medicated Ointme...
[Class : 5] Medicinal Preparations; Medicinal Healthcarepreparations;Medicinal Preparationsandsubstances;Pharmaceuticals; Homeopathic Pharmaceuticals;Pharmaceuticals,Medical And Veterinary Preparations;Dermatological Preparations; Solutions For Dermatological Use;Creams For Dermatological Use;Para Pharmaceutical Preparationsfor Use Ndermatology;Medicated Ointments For Treati...
View +39 more Brands for Epione Pharmaceuticals Private Limited.
Documents
Form DPT-3-03042021_signed
Auditor?s certificate-29122020
Form MGT-7-22112019_signed
Form AOC-4-22112019_signed
List of share holders, debenture holders;-20112019
Directors report as per section 134(3)-20112019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-20112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-20112019
Form MSME FORM I-11112019_signed
Form DPT-3-31072019-signed
Auditor?s certificate-29062019
Form MSME FORM I-08062019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29102018
Directors report as per section 134(3)-29102018
List of share holders, debenture holders;-29102018
Optional Attachment-(1)-29102018
Optional Attachment-(1)-29102018
Form DIR-12-29102018_signed
Form AOC-4-29102018_signed
Form MGT-7-29102018_signed
Evidence of cessation;-14062018
Optional Attachment-(1)-14062018
Form DIR-12-14062018_signed
Form DIR-12-19042018_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-18042018